# Sherif F. Nagueh

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/sherif-f-nagueh/

## Facts

| Field | Value |
| --- | --- |
| Citations | 49,362 |
| Field | Cardiovascular Function and Risk Factors |
| h-index | 91 |
| i10-index | 219 |
| Last Known Institution | Houston Methodist |
| OpenAlex ID | https://openalex.org/A5001463041 |
| ORCID iD | https://orcid.org/0000-0002-4911-8056 |
| Works | 424 |

## Researcher papers

- [Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging](https://scholariq.org/papers/recommendations-for-the-evaluation-of-left-ventricular-diastolic-function-by-2/)
- [Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography](https://scholariq.org/papers/recommendations-for-the-evaluation-of-left-ventricular-diastolic-function-by-3/)
- [Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography](https://scholariq.org/papers/recommendations-for-the-evaluation-of-left-ventricular-diastolic-function-by/)
- [Current and Evolving Echocardiographic Techniques for the Quantitative Evaluation of Cardiac Mechanics: ASE/EAE Consensus Statement on Methodology and Indications](https://scholariq.org/papers/current-and-evolving-echocardiographic-techniques-for-the-quantitative-2/)
- [Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial](https://scholariq.org/papers/mavacamten-for-treatment-of-symptomatic-obstructive-hypertrophic-cardiomyopathy/)
- [Current and Evolving Echocardiographic Techniques for the Quantitative Evaluation of Cardiac Mechanics: ASE/EAE Consensus Statement on Methodology and Indications Endorsed by the Japanese Society of Echocardiography](https://scholariq.org/papers/current-and-evolving-echocardiographic-techniques-for-the-quantitative/)
- [American Society of Echocardiography Consensus Statement on the Clinical Applications of Ultrasonic Contrast Agents in Echocardiography](https://scholariq.org/papers/american-society-of-echocardiography-consensus-statement-on-the-clinical/)
- [Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy](https://scholariq.org/papers/evaluation-of-mavacamten-in-symptomatic-patients-with-nonobstructive/)
- [Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity](https://scholariq.org/papers/common-genetic-variants-and-modifiable-risk-factors-underpin-hypertrophic/)
- [Simvastatin Induces Regression of Cardiac Hypertrophy and Fibrosis and Improves Cardiac Function in a Transgenic Rabbit Model of Human Hypertrophic Cardiomyopathy](https://scholariq.org/papers/simvastatin-induces-regression-of-cardiac-hypertrophy-and-fibrosis-and-improves/)
- [Distinct Subgroups in Hypertrophic Cardiomyopathy in the NHLBI HCM Registry](https://scholariq.org/papers/distinct-subgroups-in-hypertrophic-cardiomyopathy-in-the-nhlbi-hcm-registry/)
- [Ethnic-Specific Normative Reference Values for Echocardiographic LA and LV Size, LV Mass, and Systolic Function](https://scholariq.org/papers/ethnic-specific-normative-reference-values-for-echocardiographic-la-and-lv-size/)

## Researcher topics

- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)
- [Cardiomyopathy and Myosin Studies](https://scholariq.org/topics/cardiomyopathy-and-myosin-studies/)
- [Cardiac Valve Diseases and Treatments](https://scholariq.org/topics/cardiac-valve-diseases-and-treatments/)
- [Cardiac pacing and defibrillation studies](https://scholariq.org/topics/cardiac-pacing-and-defibrillation-studies/)

## Researcher university

- [Houston Methodist](https://scholariq.org/institutions/houston-methodist/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.